Tuznue
Zentral zugelassenes Arzneimittel · European Medicines Agency · Deutschland
-
EMA-Produktnummer
EMEA/H/C/006252 -
ATC
L01FD01
Was die Quelle veröffentlicht
- Zulassungsinhaber
- Prestige Biopharma Belgium
- Administrativer Status
- authorised
Namen, unter denen dieser Datensatz gefunden wird
Vollständige Quelldaten
{
"inn": "trastuzumab",
"name": "Tuznue",
"holder": "Prestige Biopharma Belgium",
"orphan": false,
"endDate": null,
"generic": false,
"smpcUrl": null,
"species": null,
"atcCodes": [
"L01FD01"
],
"category": "Human",
"marketed": null,
"useDomain": "unknown",
"biosimilar": false,
"leafletUrl": null,
"medicineUrl": "https://www.ema.europa.eu/en/medicines/human/EPAR/tuznue",
"decisionDate": "2026-08-14",
"sourceStatus": "Authorised",
"supplyRegime": null,
"opinionStatus": null,
"targetSpecies": [],
"suspensionDate": null,
"activeSubstance": "trastuzumab",
"advancedTherapy": false,
"lastUpdatedDate": "2026-08-18",
"reportTimestamp": "2026-11-08T18:01:45Z",
"therapeuticArea": "Breast Neoplasms",
"emaProductNumber": "EMEA/H/C/006252",
"authorisationDate": "2024-09-19",
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "de.ema.epar"
},
"patientEligibility": "not-assessed",
"productInformation": null,
"conditionalApproval": false,
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": true,
"administrativeStatus": "authorised",
"prescriptionCategory": "unknown",
"exceptionalCircumstances": false,
"pharmacotherapeuticGroup": "Antineoplastic agents"
}
Diesen Datensatz aus Ihrer eigenen Software abrufen
Derselbe Datensatz, mit allen Feldern und seiner Herkunft, ist nur eine Anfrage entfernt. Ein API-Schlüssel ist kostenlos und funktioniert sofort.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=de" \
--data-urlencode "sourceId=de.ema.epar" \
--data-urlencode "id=de:ema:epar:EMEA-H-C-006252"